Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
04/2007
04/11/2007EP1771449A1 Histamine-3 receptor antagonists
04/11/2007CN1946686A Method for preparing pyrrolidine oximes
04/10/2007US7202368 Process for the preparation of 4-(benzimidazolymethylamino) benzamidines
04/10/2007US7202262 E.g., 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid; translation of mRNA is allowed to continue past a nonsense mutation point, resulting in the production of a full length protein; genetic disorders
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/05/2007WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/05/2007CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/04/2007CN1942457A 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
04/04/2007CN1942428A CETP inhibitors
04/03/2007US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
04/03/2007US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
03/2007
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007015809A3 Hiv reverse transcriptase inhibitors
03/29/2007US20070073093 Light emitting device and compounds for use therein
03/29/2007US20070072918 3-[3-(4-chlorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methyl-3-phenylpropan-1-amine; antidepressants; analgesics
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/28/2007EP1765768A1 Substituted acids for the treatment of respiratory diseases
03/28/2007CN1938279A Modulators of atp-binding cassette transporters
03/28/2007CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/22/2007WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors
03/22/2007WO2006047195A3 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
03/22/2007US20070066591 Compounds for treatment of cell proliferation disorder and prevention of kinesins
03/21/2007EP1764362A1 Biaryl derivatives
03/21/2007EP1764357A1 Selective androgen receptor modulators and methods of use thereof
03/20/2007US7192657 Ethynyl containing electron transport dyes and compositions
03/20/2007CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production
03/15/2007WO2007029793A1 Aryl heterocyclic derivative and bactericide for agricultural and horticultural use
03/15/2007US20070060587 Indane derivates as muscarinic receptor agonists
03/14/2007EP1761510A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines
03/14/2007EP1761485A1 Amidino compounds as cysteine protease inhibitors
03/14/2007CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds
03/14/2007CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals
03/13/2007US7189748 Compounds and methods for treating insulin resistance and cardiomyopathy
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/08/2007WO2007025718A1 Oxadiazole compounds as urokinase inhibitors
03/08/2007US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
03/08/2007CA2620683A1 Oxadiazole compounds as urokinase inhibitors
03/07/2007EP1758873A1 Ubiquitin ligase inhibitors
03/07/2007EP1758861A1 Dpp-iv inhibitors
03/01/2007WO2007022845A1 Novel materials for organic electroluminescent devices
03/01/2007US20070049594 Novel compounds and compositions as cathepsin inhibitors
02/2007
02/28/2007EP1756074A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/28/2007CN1919842A Oxdiazole derivative and application thereof in electroluminescent material
02/28/2007CN1301974C Muller Klaus-helmut
02/28/2007CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
02/27/2007US7183300 Compounds that inhibit Hiv formation for viricides and inhibition of capsid formation
02/22/2007WO2007002764A3 Di-substituted oxadiazoles as cxc-chemokine receptor ligands
02/22/2007US20070043014 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
02/22/2007US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides
02/22/2007US20070042109 Conversion of amine- to carboxyl groups on solid surfaces
02/21/2007CN1918139A Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
02/21/2007CN1918117A Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents
02/20/2007US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/20/2007CA2344574C Thyroid receptor ligands
02/15/2007WO2007017414A1 Substituted malononitrile compounds for combating animal pests
02/15/2007US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide
02/14/2007EP1751124A2 Raf modulators and methods of use
02/14/2007EP1533292B1 Dibenzylamine compound and medicinal use thereof
02/14/2007CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007CA2387198C Method for treating hair loss using thyromimetic compounds
02/08/2007WO2007015533A1 Amidine compound and herbicide
02/08/2007WO2007015414A1 OXADIAZOLE-SUBSTITUTED Sym-TRIINDOLE DERIVATIVE AND ORGANIC EL ELEMENT EMPLOYING THE SAME
02/07/2007EP1749823A1 Amine compound and organic electroluminescent element employing the same
02/07/2007CN1910156A Malononitrile compound as pesticide
02/07/2007CN1909902A Triazole, oxadiazole and thiadiazole derivatives as PPAR modulators for the treatment of diabetes
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/01/2007WO2007013830A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007WO2007013694A1 Phenoxyalkanoic acid compound
02/01/2007CA2616377A1 Nitrocatechol derivatives as comt inhibitors
01/2007
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
01/31/2007EP1746983A2 Use of ghrelin antagonists for improving cognition and memory
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants
01/30/2007US7169797 Protein-tyrosine phosphatase inhibitors and uses thereof
01/30/2007CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy
01/25/2007WO2007011003A1 Liquid crystal compound, liquid crystal composition, thin film and liquid crystal display
01/25/2007WO2007010653A1 Salt molten at room temperature and display device
01/25/2007WO2006065277A3 Heterocyclic aspartyl protease inhibitors
01/25/2007US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1900069A 2-substituted sulfonyl-5-(3,4,5-tri alkoxylphenyl) 1,3,4-oxdiazole derivatives and preparing method and use
01/23/2007US7166624 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide
01/23/2007US7166623 Pain and inflammation
01/23/2007US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome
01/23/2007US7166593 Glucocorticoid receptor modulators
01/18/2007US20070015918 Derivatives of 1,3-diones having a herbicidal activity
01/18/2007DE19782294B4 Nicht-Steroide Liganden für den Estrogenrezeptor Non-steroidal ligands for the estrogen receptor
01/17/2007EP1742942A1 Phenylthioacetic acid derivatives and use thereof
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors
01/17/2007CN1898198A Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
01/16/2007US7163942 Sulfonamide compounds for the treatment of neurodegenerative disorders
01/11/2007WO2007003960A1 Gpcr agonists
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 72